ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Cambrex will double solid-form screening in Edinburgh

by Michael McCoy
August 2, 2019 | APPEARED IN VOLUME 97, ISSUE 31

 

09731-buscon14-edinburghcxd.jpg
Credit: Cambrex
Cambrex will double its footprint in this building in Edinburgh, Scotland.

The small-molecule-drug services firm Cambrex will double the size of its solid-form screening and crystallization process development facility in Edinburgh, Scotland. To be completed by year-end, the project will allow Cambrex to add up to 40 more scientists to its 50 employees at the site. Cambrex acquired the facility with its purchase of Avista Pharma Solutions earlier this year.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment